A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia
DOI:
文献链接: https://pubmed.ncbi.nlm.nih.gov/8071269
其他信息:
PMID: 8071269
作者: M B Scharf; T Roth; G W Vogel; J K Walsh; M B Scharf; ...
摘要: Background: Zolpidem is a short-acting, nonbenzodiazepine hypnotic with rapid onset of action. Even though it is not a benzodiazepine, it binds to one of three types of central benzodiazepine receptors, showing selective binding to the type 1 benzodiazepine receptor subtype. Therapeutic hypnotic dosages do not disturb normal sleep patterns (sleep architecture).

